|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to cash flows provided by operating activities: | |||||
| Depreciation and amortization of property and equipment | |||||
| Amortization of intangible assets | |||||
| Amortization of debt issuance costs and original issue discount | |||||
| Amortization of accumulated other comprehensive gain related to interest rate swap | |||||
| Stock-based compensation | |||||
| Impairment of goodwill | |||||
| Deferred income taxes | |||||
| Gain on sale of business | |||||
| Decrease in fair value of investments | |||||
| Gain on sale of swap | |||||
| Change in fair value of warrant liability | |||||
| Change in fair value of preferred stock liability | |||||
| Dividends accrued on preferred stock liability | |||||
| Payment of dividends accrued on preferred stock liability | |||||
| Foreign currency exchange losses (gains) | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Other operating assets | |||||
| Accounts payable | |||||
| Accrued expenses and other long-term liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of software licenses | |||||
| Proceeds from sale of business | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Borrowings under revolving line of credit | |||||
| Principal payments on revolving line of credit | |||||
| Proceeds from issuance of term debt | |||||
| Principal payments of term debt | |||||
| Principal payments of finance leases | |||||
| Payment of debt issuance costs | |||||
| Proceeds from equity offering | |||||
| Payment of equity offering issuance costs | |||||
| Proceeds from issuance of preferred stock and warrant liabilities | |||||
| Payment of preferred stock liability | |||||
| Proceeds from the exercise of stock options | |||||
| Payment of tax obligations related to vested stock awards and units | |||||
| Repurchase of common stock | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Income tax refunds received | |||||
| Supplemental disclosure of non-cash investing activities: | |||||
| Capital expenditures incurred, but not yet paid | |||||
| Inventory transfers to property and equipment | |||||
| Software license acquired through investment disposal | |||||
| Supplemental disclosure of non-cash financing activities: | |||||
| Warrant liability released to additional paid-in-capital | |||||
| Fair value of vested restricted and performance-based stock grants | |||||
Loading...